<?xml version='1.0' encoding='utf-8'?>
<section xmlns="https://code.dccouncil.us/schemas/dc-library" xmlns:codified="https://code.dccouncil.us/schemas/codified" xmlns:codify="https://code.dccouncil.us/schemas/codify" xmlns:xi="http://www.w3.org/2001/XInclude" containing-doc="D.C. Code">
  <num>7-832</num>
  <heading>Definitions.</heading>
  <text>Unless otherwise specified the following definitions apply:</text>
  <para>
    <num>(1)</num>
    <text>The term “metabolic disorder” means a disorder which results in a defect in the function of a specific enzyme or protein.</text>
  </para>
  <para>
    <num>(2)</num>
    <text>The term “hypothyroidism” means those clinical conditions which result from abnormally low circulating levels of thyroid hormone.</text>
  </para>
  <para>
    <num>(3)</num>
    <text>The term “newborn” means any infant born in the District who is under 4 weeks of age.</text>
  </para>
  <para>
    <num>(4)</num>
    <text>The term “phenylketonuria,” hereinafter referred to as “PKU,” means the metabolic disease of the newborn in which metabolites of phenylalanine appear in urine.</text>
  </para>
  <para>
    <num>(5)</num>
    <text>The term “homocystinuria” means a condition resulting from one of several genetically determined errors of methionine metabolism.</text>
  </para>
  <para>
    <num>(6)</num>
    <text>The term “galactosemia” means a condition involving the inability to convert galactose to glucose.</text>
  </para>
  <para>
    <num>(7)</num>
    <text>The term “maple syrup urine disease” means a condition resulting from the impairment of branched chain alpha-ketoacid dehydrogenase.</text>
  </para>
  <para>
    <num>(8)</num>
    <text>The term “sickle hemoglobinopathy” means a condition in which a mutation in the hemoglobin results in abnormally shaped red blood cells that obstruct normal circulation and cause inadequate oxygenation of the body’s tissues and vital organs. The term “sickle hemoglobinopathy” includes sickle cell anemia (homozygous sickle cell disease), sickle cell hemoglobin C disease, and sickle cell beta thalassemia.</text>
  </para>
  <para>
    <num>(9)</num>
    <text>The terms “hospital” and “maternity center” mean those terms as they are defined in <cite path="§44-501|(a)|(1)">§ 44-501(a)(1)</cite> and (2).</text>
  </para>
  <annotations>
    <annotation doc="D.C. Law 3-65" type="History" path="§3">Apr. 29, 1980, D.C. Law 3-65, § 3, 27 DCR 1087</annotation>
    <annotation doc="D.C. Law 6-13" type="History">July 25, 1985, D.C. Law 6-13, § 2(a), 32 DCR 3235</annotation>
    <annotation type="Prior Codifications">1981 Ed., § 6-312.</annotation>
  </annotations>
</section>
